Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

International Parkinson and Movement Disorder Society
Main Content

Virtual Parkinson’s Disease Educational Course for Industry Professionals

MDS-Africa Mouvements Anormaux (Abnormal Movements) – Presented in French

Course Content Releases June 4, 2021
Live Q&A with Course Directors and Faculty on June 25, 2021

 

Register

Course Directors

Charles H. Adler, MD, PhD, Daniela Berg, MD, Roongroj Bhidayasiri, MD, FRCP, FRCPI

Faculty

Jean-Christophe Corvol, MD, PhD, Anthony Lang, OC, MD, FRCPC, Michael Okun, MD, Holly Shill, MD

Course Description

The International Parkinson and Movement Disorder Society (MDS) "Parkinson’s Disease Educational Course for Industry Professionals" is a training program designed to familiarize pharmaceutical and medical device professionals with the diagnosis, treatment, and unmet needs of patients with Parkinson’s disease.

The program aims to provide participants with a basic knowledge of this disorder from a diagnostic and therapeutic perspective, empowering them to better understand the challenges of this disorder and its treatment.

As the premier medical society in the world that focuses on movement disorders, MDS is uniquely positioned to provide a program that will help industry professionals better understand Parkinson’s disease and give them the ability to work in a more informed manner.

On Demand Presentations

Session 1

What is Parkinson’s Disease? Pathology, Genetics, MDS Clinical Diagnostic Criteria

Charles H. Adler, MD, PhD

Session 2

Initial Evaluation: Testing, Differential Diagnosis

Daniela Berg, MD

Session 3

Progression of PD and Treatment of Early PD

Jean-Christophe Corvol, MD, PhD

Session 4

Management of Advanced PD: Motor Fluctuations and Dyskinesias

Roongroj Bhidayasiri, MD

Session 5

Invasive treatments for Parkinson’s Disease

Michael Okun, MD

Session 6

Non-Motor Signs and Symptoms: From Prodromal to Advanced Parkinson’s Disease

Holly Shill, MD

Session 7

Unmet Needs and Emerging Therapies for Parkinson’s Disease

Anthony Lang, MD

Interactive Components

Live Q&A session on Friday, June 25, 2021

Target Audience

Industry professionals who work for pharmaceutical and medical device companies.

Learning Objectives 
  1. Recognize the differential diagnosis of Parkinson’s disease
  2. Discuss the clinical features of Parkinson’s disease from early to advanced stages
  3. Identify the benefits, limitations and complications of currently available treatments for PD including pharmacotherapy and surgery
  4. Discuss non-motor features of Parkinson’s disease
  5. Identify outcome measures, unmet needs, emerging therapies, and biomarkers for Parkinson’s disease